226 related articles for article (PubMed ID: 31604406)
1. Diabetic Theory in Anti-Alzheimer's Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents.
Jankowska A; Wesołowska A; Pawłowski M; Chłoń-Rzepa G
Curr Med Chem; 2020; 27(39):6658-6681. PubMed ID: 31604406
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer's Disease.
Jankowska A; Wesołowska A; Pawłowski M; Chłoń-Rzepa G
Curr Med Chem; 2020; 27(32):5351-5373. PubMed ID: 31250747
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Theory in Anti-Alzheimer's Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors.
Jankowska A; Pawłowski M; Chłoń-Rzepa G
Curr Med Chem; 2021; 28(18):3535-3553. PubMed ID: 32940168
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Ligands with Glycogen Synthase Kinase 3 Inhibitory Activity as a New Direction in Drug Research for Alzheimer's Disease.
Jankowska A; Satała G; Bojarski AJ; Pawłowski M; Chłoń-Rzepa G
Curr Med Chem; 2021; 28(9):1731-1745. PubMed ID: 32338201
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
Muñoz-Jiménez M; Zaarkti A; García-Arnés JA; García-Casares N
Dement Geriatr Cogn Disord; 2020; 49(5):423-434. PubMed ID: 33080602
[TBL] [Abstract][Full Text] [Related]
6. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
[TBL] [Abstract][Full Text] [Related]
7. Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research.
Jankowska A; Wesolowska A; Pawlowski M; Chlon-Rzepa G
Curr Med Chem; 2018; 25(17):2045-2067. PubMed ID: 28554324
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
9. Can We Treat Neuroinflammation in Alzheimer's Disease?
Sánchez-Sarasúa S; Fernández-Pérez I; Espinosa-Fernández V; Sánchez-Pérez AM; Ledesma JC
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228179
[TBL] [Abstract][Full Text] [Related]
10. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
Pradhan SP; Sahu PK; Behera A
Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
[TBL] [Abstract][Full Text] [Related]
12. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y; Li X; Cheng J; Hou L
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
[TBL] [Abstract][Full Text] [Related]
14. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.
Ozben T; Ozben S
Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437
[TBL] [Abstract][Full Text] [Related]
15. Role of natural products for the treatment of Alzheimer's disease.
Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.
Femminella GD; Bencivenga L; Petraglia L; Visaggi L; Gioia L; Grieco FV; de Lucia C; Komici K; Corbi G; Edison P; Rengo G; Ferrara N
J Diabetes Res; 2017; 2017():7420796. PubMed ID: 28656154
[TBL] [Abstract][Full Text] [Related]
19. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Interventions to Attenuate Alzheimer's Disease Progression: The Story So Far.
Bazzari FH; Abdallah DM; El-Abhar HS
Curr Alzheimer Res; 2019; 16(3):261-277. PubMed ID: 30827243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
